跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37,076 条关于
“secondary primary malignancies”
全部
37,076
临床试验
24,293
药物
139
机构
52
资讯
12,592
去年
FDA Explores Integration Site Analysis to Mitigate Secondary Malignancy Risk in Gene Therapy
去年
CAR-T Therapy Linked to 8.9-Fold Increased Risk of Secondary T-Cell Lymphoma in Global Study
去年
Barzolvolimab Achieves Primary and Secondary Endpoints in Chronic Inducible Urticaria Phase 2 Trial
去年
Barzolvolimab Achieves Primary and Secondary Endpoints in Phase 2 CIndU Trial
去年
Barzolvolimab Achieves Primary and Secondary Endpoints in Phase 2 Trial for Chronic Inducible Urticaria
去年
Celldex's Barzolvolimab Meets All Primary and Secondary Endpoints in Clinical Trial
去年
Tirzepatide Achieves Primary and Secondary Endpoints in Phase 3 Trial for Weight Management
11个月前
Novartis' Cosentyx Achieves Primary and Secondary Endpoints in Phase III Polymyalgia Rheumatica Trial
去年
Bayer's Elinzanetant Shows Promise in Reducing Hot Flashes for Breast Cancer Patients
2个月前
Second Primary Malignancies Emerge as Clinically Relevant Complication of T-Cell–Engaging Bispecific Antibody Therapy
第 1 页,共 1260 页
上一页
下一页